PF-04764793
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PF-04764793, covering 2009-12-21 to 2010-02-11. Get the full timeline:
Most recent: Clinical Trial Update: Study To Estimate The Time Course Of PF-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers [Phase 1]